1. 现在已经有四个被FDA批准上市的 Prolia的biosimilar 药物 (类似generic,但因为Prolia是生物制药，所以叫biosimilar)。我下面列了出来。第一个药Jubbonti应该今年五月份开始有药，其他的三个也应该在今年有药。您去问问医生可不可以开这个药，价格优惠多少。
Jubbonti (denosumab-bbdz): Approved by the FDA in March 2024, this is a biosimilar to Prolia.
Ospomyv (denosumab-dssb): Approved by the FDA in February 2025.
Stoboclo (denosumab-bmwo): Approved by the FDA in March 2025.
Conexxence (denosumab-bnht): Approved by the FDA in March 2025.
2. Prolia的制药厂有病人资助项目，叫做AmgenSupport+, 我把链接贴在下面，您看看能不能申请药厂资助copay.
https://www.proliahcp.com/support-and-access/access-overview
